RedShift BioAnalytics
PrivateLast Round
Series E
Oct 18, 2021
Total Funding Raised
$70.18M
Company Overview
RedShift BioAnalytics is a life sciences company that provides a platform for biomolecule analysis through its proprietary Microfluidic Modulation Spectroscopy (MMS) technology.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Drug Discovery, Clinical Trials, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RedShift BioAnalytics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
RedShift BioAnalytics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Oct 18, 2021 | ||||
| Series D Extension | Feb 18, 2021 | ||||
| Series D | Jan 29, 2020 | ||||
| Series C | Mar 8, 2017 | ||||
| Series B | Apr 11, 2013 | ||||
Series A | Jan 12, 2006 |
Key People
Founding team and executive leadership
RedShift BioAnalytics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Technology Venture Partners | Series E, Series A, Series B, Series C, Series D Extension, Series D |
| Waters Corporation | Series D Extension, Series D, Series E, Series C |
| Illumina Ventures | Series E |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2025
Monthly visitors increased 82% MoM, reaching 6.2K.
- May 3, 2025
Monthly visitors increased 48% MoM.
RedShift BioAnalytics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RedShift BioAnalytics's valuation, stock price, and market status.